- Home
- SMLR vs STRO Comparison
SMLR vs STRO Comparison
Compare SMLR & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMLR
- STRO
- Stock Information
- Founded
- SMLR 2007
- STRO 2003
- Country
- SMLR United States
- STRO United States
- Employees
- SMLR N/A
- STRO N/A
- Industry
- SMLR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SMLR Health Care
- STRO Health Care
- Exchange
- SMLR Nasdaq
- STRO Nasdaq
- Market Cap
- SMLR 289.5M
- STRO 292.6M
- IPO Year
- SMLR 2014
- STRO 2018
- Fundamental
- Price
- SMLR $61.75
- STRO $2.84
- Analyst Decision
- SMLR
- STRO Strong Buy
- Analyst Count
- SMLR 0
- STRO 7
- Target Price
- SMLR N/A
- STRO $12.14
- AVG Volume (30 Days)
- SMLR 1.1M
- STRO 1.0M
- Earning Date
- SMLR 11-04-2024
- STRO 11-13-2024
- Dividend Yield
- SMLR N/A
- STRO N/A
- EPS Growth
- SMLR N/A
- STRO N/A
- EPS
- SMLR 2.04
- STRO N/A
- Revenue
- SMLR $58,938,000.00
- STRO $160,955,000.00
- Revenue This Year
- SMLR N/A
- STRO N/A
- Revenue Next Year
- SMLR N/A
- STRO N/A
- P/E Ratio
- SMLR $28.73
- STRO N/A
- Revenue Growth
- SMLR N/A
- STRO 230.90
- 52 Week Low
- SMLR $20.88
- STRO $2.45
- 52 Week High
- SMLR $79.45
- STRO $6.13
- Technical
- Relative Strength Index (RSI)
- SMLR 61.11
- STRO 41.69
- Support Level
- SMLR $57.33
- STRO $2.66
- Resistance Level
- SMLR $69.67
- STRO $2.86
- Average True Range (ATR)
- SMLR 9.09
- STRO 0.19
- MACD
- SMLR -0.32
- STRO 0.02
- Stochastic Oscillator
- SMLR 51.22
- STRO 78.00
About SMLR Semler Scientific Inc.
Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.